Utama › Kanser Payudara › Connecticut › Bridgeport
Kajian klinikal Kanser Payudara di Bridgeport, CT
21 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Bridgeport (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Stony Brook University Medical Center, Stony Brook · 18 mi jauh
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Mengambil pesertaFasa 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mi jauh
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Mengambil pesertaFasa 3
- Research Site, Stony Brook · 18 mi jauh
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Mengambil pesertaFasa 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mi jauh
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mi jauh
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Mengambil peserta
- Stony Brook Cancer Center, Stony Brook · 18 mi jauh
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Mengambil pesertaFasa 1/2
- Stony Brook University Hospital, Stony Brook · 18 mi jauh
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Mengambil pesertaFasa 3
- Stony Brook University Medical Center, Stony Brook · 18 mi jauh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Mengambil pesertaFasa 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauh
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mi jauh
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mi jauh
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mi jauh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi jauh
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi jauh
- dan 1 lagi
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Mengambil pesertaFasa 2
- Stony Brook Cancer Center, Stony Brook · 18 mi jauh
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Mengambil pesertaFasa 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mi jauh
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mi jauh
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Mengambil pesertaFasa 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mi jauh
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Mengambil pesertaFasa 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauh
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Mengambil pesertaFasa 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mi jauh
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi jauh
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi jauh
- Stony Brook University Medical Center, Stony Brook · 18 mi jauh
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Mengambil pesertaKajian pemerhatian
- Stony Brook Medicine, Stony Brook · 18 mi jauh
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Mengambil pesertaFasa awal 1
- Stony Brook Breast Center, Stony Brook · 18 mi jauh
Definitive Radiation Therapy for Inoperable Breast Cancer
Mengambil peserta
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauh
Definitive Radiation for High-Risk Spine Metastases
Mengambil pesertaFasa 2
- Stony Brook University Hospital, Stony Brook · 18 mi jauh
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Mengambil pesertaKajian pemerhatian
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauh
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Bridgeport
- Kanser Paru-paru Bukan Sel Kecil14 kajian
- Kanser Paru-paru13 kajian
- Leukemia Mieloid Akut12 kajian
- Penyakit Kardiovaskular9 kajian
- Kanser (semua jenis)8 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher8 kajian
- Kanser Metastatik7 kajian
- Kegagalan Jantung7 kajian
- Aneurisma Otak6 kajian
- Mieloma Pelbagai6 kajian
- Kanser Prostat6 kajian
- Kanser Ovari5 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.